ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
3.155
+0.255 (8.79%)
Jun 6, 2025, 1:27 PM - Market open

ImmunityBio Market Cap

ImmunityBio has a market cap or net worth of $2.78 billion as of June 6, 2025. Its market cap has decreased by -42.80% in one year.

Market Cap
2.78B
Enterprise Value
3.32B
1-Year Change
-42.80%
Ranking
Category
Stock Price
$3.16

Market Cap Chart

Since July 28, 2015, ImmunityBio's market cap has increased from $2.67B to $2.78B, an increase of 4.45%. That is a compound annual growth rate of 0.44%.

History

DateMarket Cap% Change
Jun 5, 20252.56B43.48%
Dec 31, 20241.78B-46.78%
Dec 29, 20233.35B65.16%
Dec 30, 20222.03B-16.05%
Dec 31, 20212.42B67.01%
Dec 31, 20201.45B288.28%
Dec 31, 2019372.80M305.66%
Dec 31, 201891.90M-74.24%
Dec 29, 2017356.80M-24.28%
Dec 30, 2016471.20M-66.52%
Dec 31, 20151.41B-47.21%
View and export this data all the way back to 2015. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 674.00B
Johnson & Johnson 371.55B
AbbVie 330.76B
Novo Nordisk 315.80B
UnitedHealth Group 273.25B
Abbott Laboratories 232.63B
Novartis AG 226.74B
AstraZeneca 223.00B
Market Cap Rankings